{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:59:23Z","timestamp":1750309163280,"version":"3.41.0"},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443343858"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.03.002","type":"book-chapter","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:43:39Z","timestamp":1743745419000},"page":"231-268","source":"Crossref","is-referenced-by-count":0,"title":["Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?"],"prefix":"10.1016","author":[{"given":"Iva","family":"Totomanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline C.H.M.","family":"Haijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra P.M.","family":"Hurks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes G.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim P.C.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-024-02900-4","article-title":"LSD increases sleep duration the night after microdosing","volume":"14","author":"Allen","year":"2024","journal-title":"Translational Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12954-019-0308-4","article-title":"Psychedelic microdosing benefits and challenges: An empirical codebook","volume":"16","author":"Anderson","year":"2019","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","article-title":"Microdosing psychedelics: Personality, mental health, and creativity differences in microdosers","volume":"236","author":"Anderson","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12954-019-0333-3","article-title":"Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube","volume":"16","author":"Andersson","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/bs.irn.2025.03.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103518","article-title":"Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting","volume":"100","author":"Argento","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Archives of Medical Science"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1017\/S1461145711000502","article-title":"Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity","volume":"14","author":"Bergman","year":"2011","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib9","first-page":"461","article-title":"Preliminary report on the effects of a low dose of LSD on resting-state amygdala functional connectivity","volume":"5","author":"Bershad","year":"2020","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","article-title":"Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers","volume":"86","author":"Bershad","year":"2019","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib11","first-page":"230","article-title":"Mindfulness: A proposed operational definition","volume":"11","author":"Bishop","year":"2004","journal-title":"Clinical Psychology: Science and Practice"},{"key":"10.1016\/bs.irn.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF \u2013 A key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1515\/revneuro-2020-0132","article-title":"Default mode network activity in depression subtypes","volume":"32","author":"Borserio","year":"2021","journal-title":"Reviews in the Neurosciences"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02791072.2020.1718250","article-title":"Psychedelic microdosing: Prevalence and subjective effects","volume":"52","author":"Cameron","year":"2020","journal-title":"Journal of Psychoactive Drugs"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacological Reviews"},{"issue":"15","key":"10.1016\/bs.irn.2025.03.002_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"Journal of Psychopharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.002_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.214","article-title":"The human BDNF gene: Peripheral gene expression and protein levels as biomarkers for psychiatric disorders","volume":"6","author":"Cattaneo","year":"2016","journal-title":"Translational Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anclin.2016.01.007","article-title":"Assessing and managing sleep disturbance in patients with chronic pain","volume":"34","author":"Cheatle","year":"2016","journal-title":"Anesthesiology Clinics"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.002_bib22","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.npp.1301593","article-title":"Functional coupling of the amygdala in depressed patients treated with antidepressant medication","volume":"33","author":"Chen","year":"2008","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"49","key":"10.1016\/bs.irn.2025.03.002_bib23","doi-asserted-by":"crossref","first-page":"17753","DOI":"10.1523\/JNEUROSCI.3272-12.2012","article-title":"Altered functional brain connectivity in a non-clinical sample of young adults with attention-deficit\/hyperactivity disorder","volume":"32","author":"Cocchi","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2025.03.002_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bandc.2014.02.001","article-title":"The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD","volume":"86","author":"Cooper","year":"2014","journal-title":"Brain and Cognition"},{"key":"10.1016\/bs.irn.2025.03.002_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.janxdis.2015.12.001","article-title":"A systematic review of sleep disturbance in anxiety and related disorders","volume":"37","author":"Cox","year":"2016","journal-title":"Journal of Anxiety Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial","volume":"8","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neubiorev.2019.07.021","article-title":"Depression biomarkers using non-invasive EEG: A review","volume":"105","author":"de Aguiar Neto","year":"2019","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13143","article-title":"Repeated low doses of LSD in healthy adults: A placebo-controlled, dose\u2013response study","volume":"27","author":"de Wit","year":"2022","journal-title":"Addiction Biology"},{"key":"10.1016\/bs.irn.2025.03.002_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/7854_2015_5004","article-title":"Translational assessment of reward and motivational deficits in psychiatric disorders","volume":"28","author":"Der-Avakian","year":"2016","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): A systematic review of clinical trials published in the last 25 years","volume":"6","author":"dos Santos","year":"2016","journal-title":"Therapeutic Advances in Psychopharmacology"},{"year":"2011","series-title":"The psychedelic explorer\u2019s guide: Safe, therapeutic, and sacred journeys","author":"Fadiman","key":"10.1016\/bs.irn.2025.03.002_bib32"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/jcmm.14170","article-title":"Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment","volume":"23","author":"Fang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S2215-0366(20)30136-X","article-title":"Sleep disturbance and psychiatric disorders","volume":"7","author":"Freeman","year":"2020","journal-title":"The Lancet Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089129","article-title":"Abnormal striatal BOLD responses to reward anticipation and reward delivery in ADHD","volume":"9","author":"Furukawa","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.002_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fpsyt.2019.00955","article-title":"Persisting reductions in cannabis, opioid, and stimulant misuse after naturalistic psychedelic use: An online survey","volume":"10","author":"Garcia-Romeu","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41386-022-01479-y","article-title":"Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity","volume":"48","author":"Glazer","year":"2023","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/bs.irn.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.002_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"Journal of psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcultural Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2021.2022254","article-title":"The psychedelic renaissance in clinical research: A bibliometric analysis of three decades of human studies with psychedelics","volume":"55","author":"Hadar","year":"2023","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/bs.irn.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2016.10.016","article-title":"Neural complexity as a potential translational biomarker for psychosis","volume":"216","author":"Hager","year":"2017","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/bs.irn.2025.03.002_bib49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: A prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.002_bib50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.002_bib51","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1007\/s00213-022-06249-8","article-title":"Set and setting in microdosing: An oft-overlooked principle","volume":"239","author":"Hartogsohn","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose\u2013effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fpsyt.2020.00224","article-title":"Depression, mindfulness, and psilocybin: Possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression. A review","volume":"11","author":"Heuschkel","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: A randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cpt.2057","article-title":"Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants","volume":"109","author":"Holze","year":"2021","journal-title":"Clinical Pharmacology & Therapeutics"},{"year":"1976","series-title":"Interview with Albert Hofmann, the man who first synthesized LSD","author":"Horowitz","key":"10.1016\/bs.irn.2025.03.002_bib56"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease\u2014It was meant 2B","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib58","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","article-title":"Motives and side-effects of microdosing with psychedelics among users","volume":"22","author":"Hutten","year":"2019","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fpsyt.2019.00672","article-title":"Self-rated effectiveness of microdosing with psychedelics for mental and physical health problems among microdosers","volume":"10","author":"Hutten","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.002_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-024-03013-8","article-title":"Inter-individual variability in neural response to low doses of LSD","volume":"14","author":"Hutten","year":"2024","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.002_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-psych-010213-115205","article-title":"Why sleep is important for health: A psychoneuroimmunology perspective","volume":"66","author":"Irwin","year":"2014","journal-title":"Annual Review of Psychology"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib64","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/JCP.0000000000000941","article-title":"Digit symbol substitution test: The case for sensitivity over specificity in neuropsychological testing","volume":"38","author":"Jaeger","year":"2018","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2016","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib66","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41598-021-81446-7","article-title":"Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing","volume":"11","author":"Kaertner","year":"2021","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib67","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/00207450390200963","article-title":"Quantitative EEG analysis in obsessive compulsive disorder","volume":"113","author":"Karadag","year":"2003","journal-title":"The International Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbr.2011.04.025","article-title":"The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety","volume":"223","author":"Kim","year":"2011","journal-title":"Behavioural Brain Research"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.drudis.2016.11.022","article-title":"Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs","volume":"22","author":"Kube","year":"2017","journal-title":"Drug Discovery Today"},{"key":"10.1016\/bs.irn.2025.03.002_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320950567","article-title":"The therapeutic potential of microdosing psychedelics in depression","volume":"10","author":"Kuypers","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib71","series-title":"Modern CNS drug discovery: Reinventing the treatment of psychiatric and neurological disorders","first-page":"257","article-title":"Microdosing psychedelics as a promising new pharmacotherapeutic","author":"Kuypers","year":"2021"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.002_bib72","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: More questions than answers? An overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib73","unstructured":"Kuypers, K. P. C. (2024). Safety and Efficacy of Repeated Low Dose d-Lysergic Acid Diethylamide (LSD) D-tartrate (MM-120) as Treatment for ADHD in Adults: A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2a Proof of Concept Trial (Clinical Trial Registration No. NCT05200936). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05200936."},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","article-title":"Psychedelic microdosing: A subreddit analysis","volume":"52","author":"Lea","year":"2020","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/bs.irn.2025.03.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Microdosing psychedelics: Motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib76","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","article-title":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","volume":"237","author":"Lea","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib77","article-title":"How LSD microdosing became the hot new business trip","author":"Leonard","year":"2015","journal-title":"Rolling Stone"},{"key":"10.1016\/bs.irn.2025.03.002_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2021_270","article-title":"Dosing psychedelics and MDMA","volume":"56","author":"Liechti","year":"2021","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ptj\/pzy027","article-title":"Understanding the etiology of chronic pain from a psychological perspective","volume":"98","author":"Linton","year":"2018","journal-title":"Physical Therapy"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jamapsychiatry.2016.3084","article-title":"Disruption of reward processing in addiction: An image-based meta-analysis of functional magnetic resonance imaging studies","volume":"74","author":"Luijten","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.002_bib81","doi-asserted-by":"crossref","unstructured":"Madsen, M. K., Petersen, A. S., Stenb\u00e6k, D. S., S\u00f8rensen, I. M., Schi\u00f8nning, H., Fjeld, T., & Knudsen, G. M. (2022). Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity (p. 2022.07.10.22277414). medRxiv. https:\/\/doi.org\/10.1101\/2022.07.10.22277414.","DOI":"10.1101\/2022.07.10.22277414"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib82","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2021.09.026","article-title":"Moment-to-moment brain signal variability reliably predicts psychiatric treatment outcome","volume":"91","author":"M\u00e5nsson","year":"2022","journal-title":"Biological Psychiatry"},{"issue":"16","key":"10.1016\/bs.irn.2025.03.002_bib83","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.neuron.2023.04.023","article-title":"20 years of the default mode network: A review and synthesis","volume":"111","author":"Menon","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1037\/abn0000013","article-title":"Dysfunctional modulation of default mode network activity in attention-deficit\/hyperactivity disorder","volume":"124","author":"Metin","year":"2015","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1016\/bs.irn.2025.03.002_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib86","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41386-023-01772-4","article-title":"Greater subjective effects of a low dose of LSD in participants with depressed mood","volume":"49","author":"Molla","year":"2024","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.002_bib87","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib88","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12868-024-00844-5","article-title":"Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial","volume":"25","author":"Murphy","year":"2024","journal-title":"BMC Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib89","first-page":"500","article-title":"Microdosing psychedelics: Current evidence from controlled studies","volume":"9","author":"Murphy","year":"2024","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib90","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopsych.2023.03.013","article-title":"Acute mood-elevating properties of microdosed lysergic acid diethylamide in healthy volunteers: A home-administered randomized controlled trial","volume":"94","author":"Murphy","year":"2023","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.002_bib91","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41386-024-01809-2","article-title":"Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine","volume":"49","author":"Murray","year":"2024","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib92","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-021-05991-9","article-title":"Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults","volume":"239","author":"Murray","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib95","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2012.06751.x","article-title":"Functional imaging studies of emotion regulation: A synthetic review and evolving model of the cognitive control of emotion","volume":"1251","author":"Ochsner","year":"2012","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.irn.2025.03.002_bib96","unstructured":"Petranker, R. (2023). Microdosing Psychedelics to Improve Mood (Clinical Trial Registration No. NCT05259943). clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05259943."},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881120953994","article-title":"Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention","volume":"36","author":"Petranker","year":"2022","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955\u20132021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.002_bib99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/02698811241254831","article-title":"Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research","volume":"38","author":"Polito","year":"2024","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.002_bib101","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.002_bib102","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib103","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269881120940937","article-title":"A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","volume":"35","author":"Ramaekers","year":"2020","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fpsyt.2014.00017","article-title":"Reduced intrinsic connectivity of amygdala in adults with major depressive disorder","volume":"5","author":"Ramasubbu","year":"2014","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib105","article-title":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","volume":"12","author":"Rootman","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01811-4","article-title":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","volume":"11","author":"Rootman","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2025.03.002_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Frontiers in Human Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib108","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/0269881120908004","article-title":"Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities","volume":"34","author":"Rosenbaum","year":"2020","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib109","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/02698811231225609","article-title":"Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins","volume":"38","author":"Rouaud","year":"2024","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib111","doi-asserted-by":"crossref","unstructured":"Sadibolova, R., Murray-Lawson, C., Family, N., Williams, L. T. J., Luke, D. P., & Terhune, D. B. (2023). LSD microdosing attenuates the impact of temporal priors in time perception (p. 2023.04.14.536983). bioRxiv. https:\/\/doi.org\/10.1101\/2023.04.14.536983.","DOI":"10.1101\/2023.04.14.536983"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib112","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory controlled study of the migraine-suppressing effects of psilocybin","volume":"18","author":"Schindler","year":"2021","journal-title":"Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.002_bib113","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-017-4713-7","article-title":"The 21st century psychedelic renaissance: Heroic steps forward on the back of an elephant","volume":"235","author":"Sessa","year":"2018","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib114","first-page":"32","article-title":"Mindfulness-based interventions in psychiatry","volume":"16","author":"Shapero","year":"2018","journal-title":"Focus (San Francisco, Calif.)"},{"key":"10.1016\/bs.irn.2025.03.002_bib115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/NSS.S226834","article-title":"The relationship of sleep duration with ethnicity and chronic disease in a canadian general population cohort","volume":"12","author":"Singh","year":"2020","journal-title":"Nature and Science of Sleep"},{"key":"10.1016\/bs.irn.2025.03.002_bib116","article-title":"Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-de\ufb01cit\/hyperactivity disorder","author":"Sonuga-Barke","year":"2010","journal-title":"Adolescent Psychiatry"},{"issue":"S2","key":"10.1016\/bs.irn.2025.03.002_bib117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13580","article-title":"Neural plasticity and behavior \u2013 Sixty years of conceptual advances","volume":"139","author":"Sweatt","year":"2016","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2025.03.002_bib118","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"eLife"},{"key":"10.1016\/bs.irn.2025.03.002_bib119","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.pnpbp.2012.05.001","article-title":"Complexity of spontaneous brain activity in mental disorders","volume":"45","author":"Takahashi","year":"2013","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib120","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.mehy.2006.06.025","article-title":"Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: Clinical and therapeutic implications","volume":"68","author":"Tsai","year":"2007","journal-title":"Medical Hypotheses"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.002_bib121","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000540062","article-title":"Psychedelics: From cave art to 21st-century medicine for addiction","volume":"30","author":"Vamvakopoulou","year":"2024","journal-title":"European Addiction Research"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.002_bib122","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00213-021-05857-0","article-title":"Effects of psilocybin microdosing on awe and aesthetic experiences: A preregistered field and lab-based study","volume":"239","author":"van Elk","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90343-y","article-title":"Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis","volume":"11","author":"Vizeli","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2025.03.002_bib124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1179\/108331907X223001","article-title":"The psychology of chronic pain and its management","volume":"12","author":"Vlaeyen","year":"2007","journal-title":"Physical Therapy Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2008.02.006","article-title":"Effects of varied doses of psilocybin on time interval reproduction in human subjects","volume":"435","author":"Wackermann","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2025.03.002_bib126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/NSS.S163074","article-title":"Sleep disorders in patients with ADHD: Impact and management challenges","volume":"10","author":"Wajszilber","year":"2018","journal-title":"Nature and Science of Sleep"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.002_bib127","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/wps.20238","article-title":"How important are the common factors in psychotherapy? An update","volume":"14","author":"Wampold","year":"2015","journal-title":"World Psychiatry: Official Journal of the World Psychiatric Association (WPA)"},{"key":"10.1016\/bs.irn.2025.03.002_bib128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugpo.2019.04.013","article-title":"Narrative identity, rationality, and microdosing classic psychedelics","volume":"70","author":"Webb","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.002_bib129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","article-title":"Reward processing dysfunction in major depression, bipolar disorder and schizophrenia","volume":"28","author":"Whitton","year":"2015","journal-title":"Current Opinion in Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.002_bib130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","article-title":"The effects of microdose LSD on time perception: A randomised, double-blind, placebo-controlled trial","volume":"236","author":"Yanakieva","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2025.03.002_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1183740","article-title":"Psychedelic therapy in the treatment of addiction: The past, present and future","volume":"14","author":"Zafar","year":"2023","journal-title":"Frontiers in Psychiatry"}],"container-title":["International Review of Neurobiology","Psychedelics in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:53:29Z","timestamp":1750287209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443343858"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.03.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2025]]}}}